Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

R E P O R T CO D E : AR M M R 1 5 1 REPORT PRICE: US$4710

CORD BLOOD, EMBRYONIC AND


ADULT STEM CELLS
APPLICATIONS & TECHNOLOGIES
– A GLOBAL MARKET WATCH, 2009-2015
PUBLICATION: MAY 2011

“Opening the Pages…….” Report Focus


1. STEM CELL PRODUCTS The ‘Cord Blood, Embryonic and Adult Stem Cells Applications &
ADULT STEM CELLS Technologies – A Global Market Watch, 2009-2015’ reviews the latest stem
CORD BLOOD STEM CELLS cells market trends with a perceptive to disclose the near-future growth
prospects. An in-depth analysis across the geographic regions provides
EMBRYONIC STEM CELLS
strategic business intelligence for life science and as well as healthcare
OTHER STEM CELLS
sector investments. The study offers profitable investment strategies for
stem cell banks, stem cells R&D organizations, pharmaceutical
2. STEM CELL APPLICATIONS manufacturers, biotechnology companies, laboratories, Contract
BONE & CARTILAGE Research Organizations (CROs) and many more in preferred locations.
CARDIAC
Estimates are based on online surveys using customized questionnaires by
SKIN
our research team. Besides information from government databases,
DIABETES
company websites, press releases and published research reports are also
BLOOD DISORDERS used for estimates. Estimates have incorporated recessionary impact on
NEURO the stem cells industry.
CANCER
DIGESTIVE SYSTEM
DRUG DEVELOPMENT
EYES Global Market Watch
INJURIES Global stem cells market is forecasted to reach US$63.8 billion by 2015
REPRODUCTIVE SYSTEM AND from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold
OTHERS growth rate during the period 2010-2015. The major application use in
stem cells market is classified into oncology, cardiology, and bone &
3. STEM CELLS TECHNOLOGIES cartilage. Among the applications areas, neurology is forecasted to
exert highest support to the stem cells market growth with a CAGR of
CELL BASED TECHNOLOGIES
24.4% during 2010-2015. Hematology and diabetes are expected to
CORD BLOOD BANKING
lead the stem cell market during 2010-2015. Our study on the stem cell

Copyright © 2011 | Axis Research Mind | All Rights Reserved


CRYOPRESERVATION
technologies reveals that cord blood banking and xenotransplantation
STEM CELL BANKING are expected to lead the technologies during 2010-2015. Drug discovery
STEM CELL CHARACTERIZATION and stem cell transplantation techniques are also expected to ground in
STEM CELL DRUG DISCOVERY the upcoming years.
STEM CELL PRODUCTION
The stem cell market is expected to witness a substantial growth in the
STEM CELL TRANSPLANTS
upcoming years, with a CAGR of 24.2%, globally. Although North
XENOTRANSPLANTATION
America will likely post highest market value by 2015, Asian economies
OTHERS* are expected to maintain large CAGR of 27 percent during 2010-2015.
The higher growth rate indicates improved industry investments in the
*Blood Transfusion, Molecular Biology and Others
Asia-Pacific region in comparison with North America and Europe, going
ahead.
R E P O R T CO D E : AR M M R 1 5 1 REPORT PRICE: US$ 4710

CORD BLOOD, EMBRYONIC AND ADULT STEM CELLS


PUBLICATION: MAY 2011
APPLICATIONS & TECHNOLOGIES

“GETTING THE MOST FROM OUR Key Activities Around Stem Cells Market
RESEARCH ANALYSIS”
 SPECIAL HUMAN CELLS DERIVED FROM STEM CELLS RESTORE
Improving health consciousness in Europe MOVEMENT IN RATS WITH SPINAL CORD INJURY
will likely maintain the Union competent  ASTROCYTES DERIVED FROM HUMAN STEM CELLS IMPROVE
with Asia-Pacific/North America. India THE LOCOMOTOR FUNCTIONS OF RATS WITH SPINAL CORD
possesses the potential to occupy the INJURY
leading position in stem cell market
 CORD BLOOD AMERICA PURCHASE OF CORD BLOOD STEM
growth with a CAGR exceeding 28
CELLS STORED BY REPRODUCTIVE GENERATIVE INSTITUTE AN
percent through 2015. Spain, Sweden and
ILLINOIS FIRM
Germany are anticipated to top among
the European countries with an annual  LIFESPAN OF BONE MARROW STEM CELLS PREDICTED
compounded growth rate of more than THROUGH COMPUTER MODEL, SOLVES THE REGENERATIVE
27 percent respectively through 2010- PROBLEMS
2015. Latin American countries will not
 RECENT STUDY REVEAL A COMBINATION OF CELLASTIM AND
likely experience a massive growth rate in
OPTIFERRIN IS IDEAL FOR STEM CELL EXPANSION WHICH
comparison with North American/Asian
REPLACES NEED OF BLOOD PRODUCTS
economies. Overall, emerging economies
could tag higher growth rate stem cells  SINGLE BLASTOMERE TECHNOLOGY SECURES PATENT TO
market in the next few years. GENERATE EMBRYONIC STEM CELLS ENSURING EMBRYO
New trends in stem cell technologies SAFETY
realized multidisciplinary research  MESENCHYMAL STEM CELLS TO IMPROVE THE DAMAGED
consortia among academic, medical, CELLS AFTER HEART ATTACK
government and industry partners.
Anticipating a boom in technological  STEMCELLS, INC. COMPLETES SECOND TRIAL OF HUCNS-SC(R)
space, the consortia members are NEURAL STEM CELLS, A POTENTIAL TREATMENT FOR
expected to be benefitted in the MYELINATION DISORDER
application front and in practicing stem-
cell technology in life science arena.
& many more….

“Stem cell banking, the latest development for stem cell preservation is planning ahead by preserving stem cells that
are obtained by amniotic fluids. It is very easy to collect the amniotic fluid during prenatal tests through our
pregnancy. Stem cell preservation from amniotic fluids is gaining momentum in US after Europe.
The families storing amniotic fluids now can give better options for their children in tissue generation
for the future can be of use in future for tissue generation”.

Stem Cell Applications - 2011 Stem Cell Technologies - 2011


Eyes
Digestive
Injuries Syetem Xenotransplantation Cryopreservation
Drug

Copyright © 2011 | Axis Research Mind | All Rights Reserved


Development Reproductive Stem Cell
System Characterization
Dermatology Stem Cell
Cord Blood Banking Transplants
Neurology
Diabetes
2011
Stem Cell
Production
2011
Stem Cell Banking
Hematology Oncology Stem Cell Drug
Bone & Discovery Cell Based
Cartilage Technologies
Cardiology
R E P O R T CO D E : AR M M R 1 5 1 REPORT PRICE: US$ 4710

CORD BLOOD, EMBRYONIC AND ADULT STEM CELLS PUBLICATION: MAY 2011
APPLICATIONS & TECHNOLOGIES

Geographic Coverage Key Company Profiles


Cord Blood, Embryonic and Adult Stem Cells Applications &  AASTROM BIOSCIENCES, INC.
Technologies Current Trends, Estimates and Forecasts analyzed
 ACORDA THERAPEUTICS, INC.
are of global coverage for, 2009-2015. The report consists of 692
pages with 508 data tables/charts of detailed analysis of Stem  ADVANCED CELL TECHNOLOGY, INC.
Cells product segments and therapeutic areas, market shares,
 AFFYMETRIX, INC
sales forecasts which gives a deep insight of the global market.
More than 500 companies identified into Stem Cells Industry.  ALPHA CORD, INC
The key strategic activities (mergers/acquisitions,  ANGIOBLAST SYSTEMS, INC.
collaborations/partnerships, product launches/developments)
 BIOHEART, INC
and 37 key companies profiled in this report with their contacts.
 BOEHRINGER-INGELHEIM GMBH
The Global Coverage of Stem Cells Market and Technologies
are North America, Europe, Asia-Pacific, Latin America and  CELL THERAPEUTICS, INC.
Rest of World with 21 countries, analyzed individually as follows:
 CELLS4LIFE LTD.
NORTH AMERICA ASIA-PACIFIC  CORCELL, INC.
USA AUSTRALIA  CORD BLOOD REGISTRY
CANADA & CHINA
 CORDLIFE LTD.
MEXICO INDIA
JAPAN  CRYOCORD SDN. BHD.
EUROPE
SOUTH KOREA &  CRYOLIFE INC.
BELGIUM
REST OF ASIA-PACIFIC2  GE HEALTHCARE
DENMARK
FRANCE LATIN AMERICA  NEOSTEM, INC.
GERMANY ARGENTINA &  OSIRIS THERAPEUTICS, INC.
GREECE BRAZIL
 RELIANCE LIFE SCIENCES
SPAIN REST OF THE WORLD  RENEURON GROUP PLC.
SWEDEN COLUMBIA
 SANOFI-AVENTIS
UNITED KINGDOM & MIDDLE EAST
REST OF EUROPE1  SPECTROCELL
SOUTH AFRICA &
REST OF REST OF WORLD  STEM CELL INNOVATIONS, INC.
 STEM CELLS THERAPEUTICS CORP
1. Rest of Europe Includes Austria, Poland, Switzerland, Finland,
The Netherlands and Others.
 STEM CELLS, INC.

Reserved
Rights Reserved
2. Rest of Asia-Pacific Includes Hong Kong, New Zealand, Singapore, Taiwan
and Others.  STEMCELL TECHNOLOGIES, INC.
 STEMLIFELINE SCIENCES, INC.
All Rights

 THERAVITAE CO., LTD.


Mind || All

 THERMO FISHER SCIENTIFIC, INC.


Research Mind

 VIACELL, INC.
Axis Research

 VITAL THERAPIES, INC.

AXIS RESEARCH MIND


2011 || Axis

& many more…


© 2010
Copyright ©
Copyright

You might also like